News
Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the first quarter of 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback